These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 471491)

  • 1. [Significance of peptides in the molecular etiology of uremic toxemia].
    Menyhárt J; Gróf J
    Orv Hetil; 1979 Jul; 120(30):1795-801. PubMed ID: 471491
    [No Abstract]   [Full Text] [Related]  

  • 2. Uremic middle molecules exist and are biologically active.
    Bergström J; Fürst P; Zimmerman L
    Clin Nephrol; 1979 May; 11(5):229-38. PubMed ID: 455821
    [No Abstract]   [Full Text] [Related]  

  • 3. Uremic middle molecules.
    Bergström J; Fürst P
    Clin Nephrol; 1976 Apr; 5(4):143-52. PubMed ID: 1277596
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigations on the activity of lactic dehydrogenase and its inhibitors in the serum of uremic patients during hemodialysis.
    Lutz W; Markiewicz K; Klyszejkostefanowicz L
    Acta Med Pol; 1974; 15(3):97-104. PubMed ID: 4455039
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigation of the clearance and generation rate of endogenous peptides in normal subjects and uremic patients.
    Peters JH; Gotch FA; Keen M; Berridge BJ; Chao WR
    Trans Am Soc Artif Intern Organs; 1974; 20 B():417-23. PubMed ID: 4450293
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of middle molecules in uremic patients.
    Wu ZG; Cai ZH; Lu ZN; Liao LT; Zhu SQ
    Chin Med J (Engl); 1985 Feb; 98(2):115-20. PubMed ID: 3922688
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of medium molecular weight peptides in pathologic processes].
    Snarska J; Puchalski Z
    Pol Merkur Lekarski; 2001 Jan; 10(55):62-4. PubMed ID: 11320557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Middle molecules in uremic serum, urine and dialysis fluid.
    Migone L; Dall'taglio P; Buzio C
    Clin Nephrol; 1975; 3(3):82-93. PubMed ID: 1139803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Middle molecules and the problem of endogenous intoxication in critical states of various etiologies].
    Vladyka AS; Levitskiĭ ER; Poddubnaia LP; Gabriélian NI
    Anesteziol Reanimatol; 1987; (2):37-42. PubMed ID: 3300433
    [No Abstract]   [Full Text] [Related]  

  • 10. [Uremic polyneuritis. Significance of determination of neural conduction velocity (NCV) and level of mean molecules (MM)].
    El Matri A; Ben Dridi M; Belkahia C; Ben Abdallah T; Crevat A; Ben Maiz H; Ben Ayed H
    Tunis Med; 1979; 57(6):348-51. PubMed ID: 555111
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on formation of complexes of insulin with basic peptides isolated from the plasma of uremic patients.
    Lutz W
    Acta Med Pol; 1975; 16(3):159-70. PubMed ID: 1180119
    [No Abstract]   [Full Text] [Related]  

  • 12. A uremic peptide containing polyamine: formation and possible role in uremic hypertriglyceridemia.
    Lutz W
    Physiol Chem Phys; 1980; 12(5):451-6. PubMed ID: 7010392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the molecular etiology of uremia.
    Gotch FA; Sargent JA; Peters JH
    Kidney Int Suppl; 1975 Feb; (3):276-9. PubMed ID: 1057699
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythrocyte deformability in uremic hemodialyzed patients.
    Zachee P; Boogaerts MA; Lins RL; Van den Broeck ; De Broe ME
    Clin Nephrol; 1986 Jun; 25(6):315. PubMed ID: 3731547
    [No Abstract]   [Full Text] [Related]  

  • 15. Phosphate in uremic patients during and between hemodialysis.
    Hillion D; Haas T
    Clin Nephrol; 1994 Oct; 42(4):275. PubMed ID: 7695753
    [No Abstract]   [Full Text] [Related]  

  • 16. [Amino acid composition of peptides with molecular weight between 500 and 1500 daltons isolated from uremic and normal sera].
    Montagna G; Buzio C; Del Monte G; Manari A; Migone L
    Minerva Nefrol; 1980; 27(2):383-6. PubMed ID: 7219861
    [No Abstract]   [Full Text] [Related]  

  • 17. Determination of endogenous middle molecules in normal and uremic body fluids.
    Fürst P; Zimmerman L; Bergström J
    Clin Nephrol; 1976 Apr; 3(2):178-88. PubMed ID: 1277595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retention of medium sized molecules in uremic serum].
    Dall'aglio P; Buzio C; Cambi V; Arisi L; Migone L
    Proc Eur Dial Transplant Assoc; 1972; 9():409-16. PubMed ID: 4668919
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum calcium in dialyzed uremic patients.
    Danesh BJ; Walker CH; Mathers NP
    N Engl J Med; 1970 Jul; 283(3):155-6. PubMed ID: 5423156
    [No Abstract]   [Full Text] [Related]  

  • 20. [An effect of chromatographic fraction ultrafiltrate of plasma on aggregation of blood platelets in patients with chronic uremia].
    Popławski A; Myśliwiec M
    Pol Merkur Lekarski; 1996 Oct; 1(4):246-8. PubMed ID: 9156935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.